Skip to content

The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU

The Effects of Mechanical Insufflation-exsufflation for Airway Mucus Clearance Among Mechanically Ventilated ICU Patients: a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03178565
Enrollment
170
Registered
2017-06-07
Start date
2016-12-31
Completion date
2017-11-30
Last updated
2017-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

Respiratory Failure, Mechanical Ventilation, Mechanical insufflation-exsufflation, Airway mucus clearance

Brief summary

The present study aims to evaluate the effect of mechanical insufflation-exsufflation on airway mucus clearance among mechanically ventilated ICU patients. A parallel group randomized clinical trial will be conducted in a single mixed medical-surgical ICU of a tertiary hospital in Southern Brazil. Adult ICU patients with a length of mechanical ventilation \>24 hours will be evaluated for eligibility. Patients will be randomized in a 1:1 ratio to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or standard respiratory physiotherapy without the use of the mechanical insufflation-exsufflation device (control group). The primary outcome is the amount of aspirated respiratory mucus (weight in grams) 5 minutes after the finish of respiratory physiotherapy.

Interventions

The mechanical insufflation-exsufflation device will be connected in the orotracheal tube. Four series of insufflation-exsufflation will be conducted. Each serie will be composed by 10 cycles of alternated insufflation (40 cmH2O) and exsufflation (- 40 cmH2O).

Standard chest physiotherapy will be conducted through bilateral thoracic maneuvers (percussion and vibration) followed by manual hyperinflation using a manual resuscitator bag.

Sponsors

Hospital Moinhos de Vento
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Mechanically ventilated patients will be randomized to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or to receive standard respiratory physiotherapy without the use of a mechanical insufflation-exsufflation device (control group).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years; * Admission to the ICU * Length of mechanical ventilation \> 24 hours * Stable ventilatory and hemodynamic status defined by positive end- expiratory pressure ≤ 8 cm H2O, inspiratory oxygen fraction ≤ 40%, ratio of arterial oxygen partial pressure to fractional inspired oxygen ≥ 150, respiratory rate ≤ 35 breaths per minute, heart rate ≤ 130 beats per minute and systolic blood pressure between 90 and 160 mmHg.

Exclusion criteria

* Patients with primary neuromuscular disease. * Patients in exclusive paliative care. * Patients with contraindications to the use of mechanical insufflation- Exsufflation device.

Design outcomes

Primary

MeasureTime frameDescription
Amount of aspirated secretionThis outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.Single measure of weight in grams of the aspirated secretion 5 minutes after the study intervention (mechanical insufflation-exsufflation or standard respiratory physiotherapy).

Secondary

MeasureTime frameDescription
Static lung complianceThis outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.Single measure of the static lung compliance in mL/cm H2O
Airway resistanceThis outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.Single measure of the airway resistance in cm H2O/L/s

Countries

Brazil

Contacts

Primary ContactMarcio Camillis
marciocamillis@yahoo.com.br55-51-996569173
Backup ContactCassiano Teixeira, MD
cassiano.rush@gmail.com55-51-3314-3782

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026